JP2016014009A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016014009A5 JP2016014009A5 JP2015095225A JP2015095225A JP2016014009A5 JP 2016014009 A5 JP2016014009 A5 JP 2016014009A5 JP 2015095225 A JP2015095225 A JP 2015095225A JP 2015095225 A JP2015095225 A JP 2015095225A JP 2016014009 A5 JP2016014009 A5 JP 2016014009A5
- Authority
- JP
- Japan
- Prior art keywords
- ribose
- agent
- subject
- effective amount
- per day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 6
- 206010016256 fatigue Diseases 0.000 claims 6
- 208000024891 symptom Diseases 0.000 claims 5
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010024264 Lethargy Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 206010041349 Somnolence Diseases 0.000 claims 1
- 238000005265 energy consumption Methods 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18949808P | 2008-08-20 | 2008-08-20 | |
| US61/189,498 | 2008-08-20 | ||
| US20812209P | 2009-02-20 | 2009-02-20 | |
| US61/208,122 | 2009-02-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523814A Division JP2012500261A (ja) | 2008-08-20 | 2009-08-20 | 疲労した対象のためのｄ−リボースの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016014009A JP2016014009A (ja) | 2016-01-28 |
| JP2016014009A5 true JP2016014009A5 (enExample) | 2016-03-10 |
Family
ID=41172394
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523814A Withdrawn JP2012500261A (ja) | 2008-08-20 | 2009-08-20 | 疲労した対象のためのｄ−リボースの使用 |
| JP2015095225A Pending JP2016014009A (ja) | 2008-08-20 | 2015-05-07 | 疲労した対象のためのｄ−リボースの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523814A Withdrawn JP2012500261A (ja) | 2008-08-20 | 2009-08-20 | 疲労した対象のためのｄ−リボースの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100189785A1 (enExample) |
| EP (1) | EP2323668A1 (enExample) |
| JP (2) | JP2012500261A (enExample) |
| CN (2) | CN102215846A (enExample) |
| AU (1) | AU2009283215B2 (enExample) |
| BR (1) | BRPI0917360A2 (enExample) |
| CA (1) | CA2734769A1 (enExample) |
| WO (1) | WO2010021713A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100055206A1 (en) * | 2008-04-02 | 2010-03-04 | St Cyr John A | Use of ribose in first response to acute myocardial infarction |
| CN102488669A (zh) * | 2011-12-30 | 2012-06-13 | 上海希迪制药有限公司 | 一种改善d-核糖引湿性的方法 |
| EP3215162A4 (en) * | 2014-11-03 | 2018-06-27 | Bioenergy Life Science, Inc. | Use of d-ribose to enhance adaptation to physical stress |
| WO2017120731A1 (en) * | 2016-01-11 | 2017-07-20 | Shanghai Yao Yuan Biotechnology Co., Ltd. | Methods and compositions for reducing body weight |
| JP6542687B2 (ja) | 2016-01-28 | 2019-07-10 | 日本特殊陶業株式会社 | ガスセンサユニット |
| US10434113B2 (en) | 2016-12-16 | 2019-10-08 | The Charlotte Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| WO2019200132A1 (en) * | 2018-04-12 | 2019-10-17 | Metabolic Recovery Systems, LLC | Compositions and methods for supplementing the diet |
| WO2020041750A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
| KR102435548B1 (ko) * | 2022-05-31 | 2022-08-26 | (주)에이피테크놀로지 | 액상스틱형 에너지 스포츠 음료 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4228215A1 (de) * | 1992-08-25 | 1994-03-03 | Pliml Wolfgang | Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen |
| EP1745789A1 (en) * | 1998-06-19 | 2007-01-24 | Bioenergy Inc. | Compositions comprising ribose for increasing energy in vivo |
| US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
| US6159943A (en) * | 1999-09-24 | 2000-12-12 | Bioenergy, Inc. | Use of ribose to prevent cramping and soreness in muscles |
| GB2353217B (en) * | 1999-10-27 | 2001-07-18 | Bioenergy Inc | Use of ribose to treat fibromyalgia |
| US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
| IT1317043B1 (it) * | 2000-06-14 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio. |
| US6855727B2 (en) * | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
| WO2005089774A1 (en) * | 2004-03-18 | 2005-09-29 | Tanabe Seiyaku Co., Ltd. | D-ribose for improving depression-like symptoms |
| US20100099630A1 (en) * | 2004-04-29 | 2010-04-22 | Maccarter Dean J | Method for improving ventilatory efficiency |
| WO2005107768A2 (en) * | 2004-04-29 | 2005-11-17 | Bioenergy, Inc. | Method for improving ventilatory efficiency |
| US7645742B2 (en) * | 2005-06-22 | 2010-01-12 | Advocare International, L.P. | Composition for enhancing cellular energy |
| WO2022123637A1 (ja) | 2020-12-07 | 2022-06-16 | 株式会社日立製作所 | 文書処理システムおよび文書処理方法 |
-
2009
- 2009-08-20 EP EP09789171A patent/EP2323668A1/en not_active Withdrawn
- 2009-08-20 JP JP2011523814A patent/JP2012500261A/ja not_active Withdrawn
- 2009-08-20 CN CN2009801324503A patent/CN102215846A/zh active Pending
- 2009-08-20 BR BRPI0917360A patent/BRPI0917360A2/pt not_active Application Discontinuation
- 2009-08-20 US US12/583,430 patent/US20100189785A1/en not_active Abandoned
- 2009-08-20 CA CA2734769A patent/CA2734769A1/en not_active Abandoned
- 2009-08-20 CN CN201510527242.0A patent/CN105232564A/zh active Pending
- 2009-08-20 AU AU2009283215A patent/AU2009283215B2/en active Active
- 2009-08-20 WO PCT/US2009/004738 patent/WO2010021713A1/en not_active Ceased
-
2012
- 2012-04-11 US US13/444,279 patent/US20120264701A1/en not_active Abandoned
-
2015
- 2015-05-07 JP JP2015095225A patent/JP2016014009A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016014009A5 (enExample) | ||
| IL285107A (en) | Diagnostic, prognostic and therapeutic uses of long non-coding RNA molecules for heart diseases and rehabilitation medicine | |
| PL3439660T3 (pl) | Stosowanie pimobendanu w celu redukowaniu wielkości serca i opóźnienia początku objawów klinicznych u pacjentów z bezobjawową niewydolnością serca w wyniku choroby zastawki mitralnej | |
| CN104812762A8 (en) | Substituted annulated pyrimidines and triazines, and use thereof | |
| JP2016515522A5 (enExample) | ||
| JP2014507482A5 (enExample) | ||
| MA34019B1 (fr) | Aryltriazolone liée à un bis-aryle et son utilisation | |
| DK2732757T3 (da) | Ikke-invasiv, trådløs, bærbar indretning, som kan anvendes på fingeren for at reducere risikoen for vuggedød og reducere risikoen for apnø, langsommere hjerterytme og hjertestop i alle aldersgrupper | |
| JP2015535291A5 (enExample) | ||
| BR112016007238A2 (pt) | tienouracilcarboxamidas cíclicas e sua utilização | |
| JP2013523758A5 (enExample) | ||
| JP2019528267A5 (enExample) | ||
| JP2017061488A5 (enExample) | ||
| Hagen et al. | Emerging adverse cutaneous drug reactions | |
| PT3439660T (pt) | Utilização de pimobendan para a redução do tamanho do coração e o retardamento do início de sintomas clínicos em doentes com insuficiência cardíaca assintomática devido a doença da válvula mitral | |
| Goel | Emergency care for older people in India | |
| Dhakal | Indigenous Knowledge and Global Wellness | |
| WO2014011273A3 (en) | Pro-inflammatory mediators in diagnosis and treatment of pulmonary disease | |
| ES2546766T3 (es) | Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico | |
| Senatorova et al. | MODERN PRINCIPLES OF DIAGNOSTICS AND ТАCTICS OF CARE NEWBORNS WITH CONGENITAL HEART DISEASES | |
| McDaniel et al. | The self of the medical family therapist. | |
| IT201700048039A1 (it) | Letto ideato per effettuare gli esercizi di “Training for Good Sleeping” e migliorare la qualità del sonno e della vita. | |
| Isitan | Encephalopathy: case report | |
| Kaleth et al. | To evaluate the relationship between long-term maintenance of moderate to vigorous physical activity (MVPA) and clinical outcomes in fibromyalgia (FM). | |
| Hay | Comment by: Dr Rania Mounir Abdel Hay |